Further investigation of the rapid-onset and short-duration action of the G protein-biased μ-ligand oliceridine.
Saved in:
| Title: | Further investigation of the rapid-onset and short-duration action of the G protein-biased μ-ligand oliceridine. |
|---|---|
| Authors: | Mori T; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan., Takemura Y; Department of Anesthesiology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, 930-0194, Japan., Arima T; Department of Pharmacy, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Iwase Y; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan., Narita M; Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Miyano K; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Hamada Y; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Suda Y; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Matsuzawa A; Department of Synthetic Medicinal Chemistry, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan., Sugita K; Department of Synthetic Medicinal Chemistry, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan., Matsumura S; Institute of Medicinal Chemistry, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan., Sasaki S; Institute of Medicinal Chemistry, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan., Yamauchi T; Institute of Medicinal Chemistry, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan., Higashiyama K; Institute of Medicinal Chemistry, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan., Uezono Y; Department of Pain Control Research, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461, Japan., Yamazaki M; Department of Anesthesiology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, 930-0194, Japan., Kuzumaki N; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan. Electronic address: n-kuzumaki@hoshi.ac.jp., Narita M; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Electronic address: narita@hoshi.ac.jp. |
| Source: | Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2021 Jan 01; Vol. 534, pp. 988-994. Date of Electronic Publication: 2020 Nov 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2104 (Electronic) Linking ISSN: 0006291X NLM ISO Abbreviation: Biochem Biophys Res Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33139013 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Further investigation of the rapid-onset and short-duration action of the G protein-biased μ-ligand oliceridine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mori+T%22">Mori T</searchLink>; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.<br /><searchLink fieldCode="AU" term="%22Takemura+Y%22">Takemura Y</searchLink>; Department of Anesthesiology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, 930-0194, Japan.<br /><searchLink fieldCode="AU" term="%22Arima+T%22">Arima T</searchLink>; Department of Pharmacy, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Iwase+Y%22">Iwase Y</searchLink>; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.<br /><searchLink fieldCode="AU" term="%22Narita+M%22">Narita M</searchLink>; Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Miyano+K%22">Miyano K</searchLink>; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Hamada+Y%22">Hamada Y</searchLink>; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Suda+Y%22">Suda Y</searchLink>; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Matsuzawa+A%22">Matsuzawa A</searchLink>; Department of Synthetic Medicinal Chemistry, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.<br /><searchLink fieldCode="AU" term="%22Sugita+K%22">Sugita K</searchLink>; Department of Synthetic Medicinal Chemistry, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.<br /><searchLink fieldCode="AU" term="%22Matsumura+S%22">Matsumura S</searchLink>; Institute of Medicinal Chemistry, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.<br /><searchLink fieldCode="AU" term="%22Sasaki+S%22">Sasaki S</searchLink>; Institute of Medicinal Chemistry, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.<br /><searchLink fieldCode="AU" term="%22Yamauchi+T%22">Yamauchi T</searchLink>; Institute of Medicinal Chemistry, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.<br /><searchLink fieldCode="AU" term="%22Higashiyama+K%22">Higashiyama K</searchLink>; Institute of Medicinal Chemistry, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.<br /><searchLink fieldCode="AU" term="%22Uezono+Y%22">Uezono Y</searchLink>; Department of Pain Control Research, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461, Japan.<br /><searchLink fieldCode="AU" term="%22Yamazaki+M%22">Yamazaki M</searchLink>; Department of Anesthesiology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, 930-0194, Japan.<br /><searchLink fieldCode="AU" term="%22Kuzumaki+N%22">Kuzumaki N</searchLink>; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan. Electronic address: n-kuzumaki@hoshi.ac.jp.<br /><searchLink fieldCode="AU" term="%22Narita+M%22">Narita M</searchLink>; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Electronic address: narita@hoshi.ac.jp. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372516%22">Biochemical and biophysical research communications</searchLink> [Biochem Biophys Res Commun] 2021 Jan 01; Vol. 534, pp. 988-994. <i>Date of Electronic Publication: </i>2020 Nov 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372516 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1090-2104 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220006291X%22">0006291X </searchLink><i>NLM ISO Abbreviation: </i>Biochem Biophys Res Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33139013 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.bbrc.2020.10.053 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 988 Titles: – TitleFull: Further investigation of the rapid-onset and short-duration action of the G protein-biased μ-ligand oliceridine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mori T – PersonEntity: Name: NameFull: Takemura Y – PersonEntity: Name: NameFull: Arima T – PersonEntity: Name: NameFull: Iwase Y – PersonEntity: Name: NameFull: Narita M – PersonEntity: Name: NameFull: Miyano K – PersonEntity: Name: NameFull: Hamada Y – PersonEntity: Name: NameFull: Suda Y – PersonEntity: Name: NameFull: Matsuzawa A – PersonEntity: Name: NameFull: Sugita K – PersonEntity: Name: NameFull: Matsumura S – PersonEntity: Name: NameFull: Sasaki S – PersonEntity: Name: NameFull: Yamauchi T – PersonEntity: Name: NameFull: Higashiyama K – PersonEntity: Name: NameFull: Uezono Y – PersonEntity: Name: NameFull: Yamazaki M – PersonEntity: Name: NameFull: Kuzumaki N – PersonEntity: Name: NameFull: Narita M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2021 Jan 01 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1090-2104 Numbering: – Type: volume Value: 534 Titles: – TitleFull: Biochemical and biophysical research communications Type: main |
| ResultId | 1 |